Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort.
Saved in:
| Title: | Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort. |
|---|---|
| Authors: | Yokomaku, Yoshiyuki1 (AUTHOR) yokomaku@nnh.go.jp, Teruya, Katsuji2 (AUTHOR), Watanabe, Dai3 (AUTHOR), Endo, Tomoyuki4 (AUTHOR), Minami, Rumi5 (AUTHOR), Taguchi, Nao6 (AUTHOR), Cassidy, Tali7 (AUTHOR), Marongiu, Andrea7 (AUTHOR), Thorpe, David8 (AUTHOR), Shirasaka, Takuma3 (AUTHOR), Oka, Shinichi2 (AUTHOR) |
| Source: | PLoS ONE. 1/8/2025, Vol. 20 Issue 1, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0313338 |
